Circulation 118(10):10801111 [DOI] [PubMed] [Google Scholar] 19.Jiang X, Zhao Y, Li X, Zhu H, Liu Y, Zhang Z (2022) Intermittent hypoxia and the pathogenesis of cardiovascular diseases in obstructive sleep apnea
Existing extended-release options, like weekly formulations of semaglutide and dulaglutide, have reduced injection frequency, and future innovations may include monthly formulations or implantable devices that deliver continuous therapy
Such supplements may also be comparatively inexpensive
Exenatide elicits sustained glycemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin
Step two: if it is listed, your prescriber will need to submit a prior authorization showing you meet criteria (typically BMI 30+ or BMI 27+ with a comorbidity, documented in your medical record)